Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis
Friede, Tim and Kieser, Meinhard. (2011) Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis. Pharmaceutical Statistics, Volume 10 (Number 1). pp. 8-13. ISSN 1539-1604Full text not available from this repository.
Official URL: http://dx.doi.org/10.1002/pst.398
Baseline adjusted analyses are commonly encountered in practice, and regulatory guidelines endorse this practice. Sample size calculations for this kind of analyses require knowledge of the magnitude of nuisance parameters that are usually not given when the results of clinical trials are reported in the literature. It is therefore quite natural to start with a preliminary calculated sample size based on the sparse information available in the planning phase and to re-estimate the value of the nuisance parameters (and with it the sample size) when a portion of the planned number of patients have completed the study. We investigate the characteristics of this internal pilot study design when an analysis of covariance with normally distributed outcome and one random covariate is applied. For this purpose we first assess the accuracy of four approximate sample size formulae within the fixed sample size design. Then the performance of the recalculation procedure with respect to its actual Type I error rate and power characteristics is examined. The results of simulation studies show that this approach has favorable properties with respect to the Type I error rate and power. Together with its simplicity, these features should make it attractive for practical application. (C) Copyright 2009 John Wiley & Sons, Ltd.
|Item Type:||Journal Article|
|Subjects:||Q Science > QA Mathematics
R Medicine > R Medicine (General)
|Divisions:||Faculty of Medicine > Warwick Medical School|
|Library of Congress Subject Headings (LCSH):||Analysis of covariance, Clinical trials, Clinical medicine -- Research -- Statistical methods, Sampling (Statistics)|
|Journal or Publication Title:||Pharmaceutical Statistics|
|Publisher:||John Wiley & Sons Ltd.|
|Page Range:||pp. 8-13|
|Access rights to Published version:||Restricted or Subscription Access|
|References:|| Committee for Proprietary Medicinal Products (CPMP): Points to Consider on Adjustment for Baseline Covariates, 2003. Available at: http://www.emea.europa.eu/pdfs/human/ewp/286399en.pdf (ac- cessed 31.03.2009).  Fleiss JL. The Design and Analysis of Clinical Experiments . Wiley: New York, 1986.  Bock J. Bestimmung des Stichprobenumfangs fu ̈ r biologische Experimente und kontrollierte klinische Studien . Oldenbourg: Mu ̈ nchen, 1998.  Chow SC, Shao J, Wang H. Sample Size Calculations in Clinical Research . Marcel Dekker: New York, 2003.  Pass 2008 NCSS: Kaysville Available at: http://www.ncss.com/ pass.html (accessed 31.03.2009).  nQuery Advisor s Release 7.0. Statistical So lutions: Saugus Available at: http://www.statsol.ie/index. php?pageID = 9&productID = 2 (ac- cessed 31.03.2009).  International Conference on Harmonisation. ICH Harmonised Tripartite Guideline E9: Statistical Principles for Clinical Trials, 1998. Available at: http:// www.emea.europa.eu /pdfs/human/ich/ 036396en.pdf (accessed 31.03.2009).  Committee for Medical Products for Human Use. Reflection Paper on Methodological Issues in Confirmatory Clinical Trials Planned with an Adaptive Design. CHMP/EWP/2459/02, 2007. Available at: http://www.emea.europa.eu/pdfs/human/ewp/245902enadop- ted.pdf (accessed 31.03.2009).  Schwartz TA, Denne JS. Common threads between sample size recalculation and group sequential procedures. Pharmaceutical Statistics 2003; 2 :263–271.  Friede T, Kieser M. Sample size recalculation in internal pilot study designs: a review. Biometrical Journal 2006; 48 :537–555.  Proschan MA. Sample size re-estimation in clinical trials. Bio- metrical Journal 2009; 51 :348–357.  Zucker DM, Wittes JT, Schabenberger O, Brittain E. Internal pilot studies II: comparison of various procedures. Statistics in Medicine 1999; 18 :3493–3509.  Kieser M, Friede T. Simple procedures for blinded sample size recalculation that do not affect the type I error rate. Statistics in Medicine 2003; 22 :3571–3581.  Waksman JA. Assessment of the Gould–Shih procedure for sample size re-estimation. Pharmaceutical Statistics 2007; 6 :53–65.  Coffey CS, Muller KE. Exact test size and power of a Gaussian error linear model for an internal pilot study. Statistics in Medicine 1999; 18 :1199–1214.  Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Statistics in Medicine 1999; 11 :1685–1704.  Guenther WC. Sample size formulae for normal theory t -tests. American Statistician 1981; 35 :243–244.  Schouten HJA. Sample size formula with a continuous outcome, for unequal group size and unequal variances. Statistics in Medicine 1999; 18 :87–91.  Glueck DH, Muller KE. Adjusting power for a baseline covariate in linear models. Statistics in Medicine 2003; 22 :2535–2551.  Friede T, Kieser M. A comparison of methods for adaptive sample size adjustment. Statistics in Medicine 2001; 20 :3861–3873.  Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005; 65 :812–819.  Julious SA, Mullee MA. Issues with using baseline in last observation carried forward analysis. Pharmaceutical Statistics 2008; 7 :142–146.|
Actions (login required)